Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 215

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7
Chunk 215
---
653)Liability-classified warrants(23,078)— Net loss attributable to Class A common stockholders–diluted$(158,927)$(186,426)Denominator–basic:Weighted average Class A common shares outstanding–basic145,175 94,889 Net loss per share attributable to Class A common stockholders–basic$(0.94)$(0.61)Denominator–diluted:Weighted average Class A common shares outstanding–basic145,175 94,889 Weighted average effect of dilutive securities:Shares of Class V common stock— 199,701 Liability-classified warrants1,823 — Weighted average shares outstanding–diluted146,998 294,590 Net loss per share attributable to Class A common stockholders–diluted$(1.08)$(0.63)Shares of Class V common stock do not share in the earnings or losses of P3 and are therefore not participating securities. As such, separate presentation of basic and diluted net income per share for Class V common stock under the two-class method is not required. The following table presents potentially dilutive securities excluded from the computation of diluted net loss per share for the periods presented because their effect would have been anti-dilutive.Year Ended December 31,20242023(in thousands)Stock warrants (1)179,125 81,938Stock options (1)19,517 5,837Restricted stock units (1)8,087 4,835 Shares of Class V common stock (2)195,957 — Total402,686 92,610__________________(1)Represents the number of instruments outstanding at the end of the period. Application of the treasury stock method would reduce this amount if they had a dilutive effect and were included in the computation of diluted net loss per share(2)Shares of Class V common stock at the end of the period are considered potentially dilutive shares of Class A common stock under application of the if-converted method in 2023 and antidilutive in 2024.

Note 17: Redeemable Non-controlling Interest

Non-controlling interest represents the portion of P3 LLC that the Company controls and consolidates but does not own (i.e., the Common Units held directly by equity holders other than the Company). 

P3 Health Partners Inc. | 2024 Form 10-K | 115

The ownership of the Common Units is summarized as follows:December